Author:
Mazzio Elizabeth,Soliman Karam F. A.
Reference141 articles.
1. Pal LR, Yu CH, Mount SM, Moult J (2015) Insights from GWAS: emerging landscape of mechanisms underlying complex trait disease. BMC Genomics 16(Suppl 8):S4
2. Huertas-Vazquez A, Nelson CP, Sinsheimer JS, Reinier K, Uy-Evanado A, Teodorescu C, Ayala J, Hall AS, Gunson K, Jui J et al (2015) Cumulative effects of common genetic variants on risk of sudden cardiac death. Int J Cardiol Heart Vasc 7:88–91
3. Meng W, Deshmukh HA, van Zuydam NR, Liu Y, Donnelly LA, Zhou K, Wellcome Trust Case Control Consortium 2 (WTCCC2), Surrogate Markers for Micro- and Macro-Vascular Hard Endpoints for Innovative Diabetes Tools (SUMMIT) Study Group, Morris AD et al (2015) A genome-wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic pain. Eur J Pain 19:392–399
4. Goyette P, Boucher G, Mallon D, Ellinghaus E, Jostins L, Huang H, Ripke S, Gusareva ES, Annese V, Hauser SL et al (2015) High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat Genet 47:172–179
5. Wang Y, Li D, Wei P (2015) Powerful Tukey’s One Degree-of-Freedom Test for detecting gene-gene and gene-environment interactions. Cancer Inform 14:209–218